These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 32993619

  • 1. Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae).
    Lukman V, Odeyemi SW, Roth RL, Mbabala L, Tshililo N, Vlok NM, Dewar MJB, Kenyon CP.
    BMC Biotechnol; 2020 Sep 29; 20(1):50. PubMed ID: 32993619
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profile of extracts of Pelargonium sidoides and their constituents.
    Kolodziej H, Kayser O, Radtke OA, Kiderlen AF, Koch E.
    Phytomedicine; 2003 Sep 29; 10 Suppl 4():18-24. PubMed ID: 12807338
    [Abstract] [Full Text] [Related]

  • 3. Medicinal properties and conservation of Pelargonium sidoides DC.
    Moyo M, Van Staden J.
    J Ethnopharmacol; 2014 Mar 14; 152(2):243-55. PubMed ID: 24463034
    [Abstract] [Full Text] [Related]

  • 4. The antifungal and Cryptococcus neoformans virulence attenuating activity of Pelargonium sidoides extracts.
    Samie S, Trollope KM, Joubert LM, Makunga NP, Volschenk H.
    J Ethnopharmacol; 2019 May 10; 235():122-132. PubMed ID: 30738119
    [Abstract] [Full Text] [Related]

  • 5. Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology.
    Pereira ASP, Bester MJ, Apostolides Z.
    Mol Divers; 2017 Nov 10; 21(4):809-820. PubMed ID: 28924942
    [Abstract] [Full Text] [Related]

  • 6. Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells.
    Pereira A, Bester M, Soundy P, Apostolides Z.
    Pharm Biol; 2016 Sep 10; 54(9):1831-40. PubMed ID: 26794080
    [Abstract] [Full Text] [Related]

  • 7. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme.
    Kayser O, Kolodziej H.
    Planta Med; 1997 Dec 10; 63(6):508-10. PubMed ID: 9434601
    [Abstract] [Full Text] [Related]

  • 8. Aqueous ethanolic extract of the roots of Pelargonium sidoides--new scientific evidence for an old anti-infective phytopharmaceutical.
    Kolodziej H.
    Planta Med; 2008 May 10; 74(6):661-6. PubMed ID: 18203051
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs® 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells.
    Janecki A, Conrad A, Engels I, Frank U, Kolodziej H.
    J Ethnopharmacol; 2011 Jan 07; 133(1):147-52. PubMed ID: 20883767
    [Abstract] [Full Text] [Related]

  • 10. Conservation strategy for Pelargonium sidoides DC: phenolic profile and pharmacological activity of acclimatized plants derived from tissue culture.
    Moyo M, Aremu AO, Gruz J, Subrtová M, Szüčová L, Doležal K, Van Staden J.
    J Ethnopharmacol; 2013 Sep 16; 149(2):557-61. PubMed ID: 23892203
    [Abstract] [Full Text] [Related]

  • 11. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630.
    Kolodziej H, Kiderlen AF.
    Phytomedicine; 2007 Sep 16; 14 Suppl 6():18-26. PubMed ID: 17188480
    [Abstract] [Full Text] [Related]

  • 12. Components derived from Pelargonium stimulate macrophage killing of Mycobacterium species.
    Kim CE, Griffiths WJ, Taylor PW.
    J Appl Microbiol; 2009 Apr 16; 106(4):1184-93. PubMed ID: 19191950
    [Abstract] [Full Text] [Related]

  • 13. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.
    Kolodziej H.
    Phytomedicine; 2007 Apr 16; 14 Suppl 6():9-17. PubMed ID: 17188477
    [Abstract] [Full Text] [Related]

  • 14. Chemical characterisation of Pelargonium sidoides root based on LC-QToF-MS non-target screening strategies.
    Panara A, Aalizadeh R, Thomaidis NS.
    Phytochem Anal; 2022 Jan 16; 33(1):40-56. PubMed ID: 34021648
    [Abstract] [Full Text] [Related]

  • 15. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children?
    Tahan F, Yaman M.
    Phytomedicine; 2013 Jan 15; 20(2):148-50. PubMed ID: 23142309
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis.
    Bao Y, Gao Y, Koch E, Pan X, Jin Y, Cui X.
    Phytomedicine; 2015 Apr 15; 22(4):504-9. PubMed ID: 25925973
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of Pelargonium sidoides in pediatric patients diagnosed with uncomplicated upper respiratory tract infection: a single-blind, randomized, placebo-controlled study.
    Gökçe Ş, Dörtkardeşler BE, Yurtseven A, Kurugöl Z.
    Eur J Pediatr; 2021 Sep 15; 180(9):3019-3028. PubMed ID: 34304301
    [Abstract] [Full Text] [Related]

  • 18. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach.
    Wittschier N, Faller G, Hensel A.
    Phytomedicine; 2007 Apr 15; 14(4):285-8. PubMed ID: 17350240
    [Abstract] [Full Text] [Related]

  • 19. The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes.
    Witte K, Koch E, Volk HD, Wolk K, Sabat R.
    PLoS One; 2015 Apr 15; 10(9):e0138075. PubMed ID: 26406906
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy.
    Patiroglu T, Tunc A, Eke Gungor H, Unal E.
    Phytomedicine; 2012 Aug 15; 19(11):958-61. PubMed ID: 22809962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.